CClinicalTrials.gg
CompletedNCT00142701Updated Feb 8, 2016

Enhancing Support for Women at Risk for Heart Disease

An interventional study of diet and physical activity in Cardiovascular Diseases, Heart Diseases and Coronary Disease, sponsored by Oregon Research Institute. Completed. Open to female participants aged Up to 100 Years. Per ClinicalTrials.gov, last updated 2016-02-08.

Sponsored by Oregon Research Institute · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Allocation
Randomized
Ages
Up to 100 Years
Sex
Female
01

Study summary

To test a practical, theory-based intervention to achieve long-term behavior change for postmenopausal women with Type 2 diabetes at high risk for developing coronary heart disease (CHD).

Read the detailed description

BACKGROUND:

The overall goal of this study was to test a practical, theory-based intervention to achieve long-term behavior change for women with Type 2 diabetes at high risk for developing coronary heart disease (CHD). Epidemiological and clinical studies suggest that diabetes is associated with increased risk for CHD that is greater in women than in men. CHD is a major cause of death and functional limitations in women, but the vast majority of CHD studies have primarily involved middle-aged men. There is convincing research evidence that healthy lifestyle behaviors, including low-fat diet, physical activity, stress management, smoking cessation, and social support, can reduce CHD risk

The study was initiated in response to a Request for Applications released in October 1997 by the National Institutes of Health Office of the Director on "Innovative Approaches to Disease Prevention Through Behavior Change."

DESIGN NARRATIVE:

The study was a randomized trial to compare short-term (6-month) outcomes in women receiving usual care compared to a modified Ornish-type comprehensive lifestyle management (CLM) intervention. Participants (N = 279) were randomized to usual care (UC) or Mediterranean Lifestyle Program, a lifestyle change intervention aimed at the behavioral risk factors (eating patterns, physical activity, stress management, and social support) affecting risk for CHD in postmenopausal women with type 2 diabetes. After 6 months, women in the CLM condition were randomized to one of two approaches for providing support either lay-led group support or personalized computer-based support - to evaluate these strategies in enhancing longer-term maintenance of effects. Outcomes included multiple CHD lifestyle behaviors (e.g., dietary intake, exercise levels, stress management, smoking cessation), physiological risk factors associated with CHD (e.g., serum lipids, hypertension, weight, vascular reactivity), HbA1c (glycated hemoglobin, a measure of diabetes), and quality of life (e.g., depression, functioning).

02

Conditions studied

  • Cardiovascular Diseases
  • Heart Diseases
  • Coronary Disease
  • Coronary Heart Disease Risk Reduction
  • Diabetes Mellitus, Non-insulin Dependent
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

Browse Cardiovascular Diseases studies →

Lead sponsor

Oregon Research Institute is the lead sponsor of 70 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 100 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

No eligibility criteria

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized

Interventions

  • Behavioraldiet
  • Behavioralphysical activity
  • Behavioralstress management
  • Behavioralsmoking cessation
06

Study locations

No study locations are listed for this record.

07

References and documents

Publications

  • Toobert DJ, Strycker LA, Glasgow RE, Barrera M Jr, Angell K. Effects of the mediterranean lifestyle program on multiple risk behaviors and psychosocial outcomes among women at risk for heart disease. Ann Behav Med. 2005 Apr;29(2):128-37. doi: 10.1207/s15324796abm2902_7. PubMed 15823786 ↗
  • Glasgow RE, Toobert DJ, Barrera M Jr, Strycker LA. The Chronic Illness Resources Survey: cross-validation and sensitivity to intervention. Health Educ Res. 2005 Aug;20(4):402-9. doi: 10.1093/her/cyg140. Epub 2004 Nov 30. PubMed 15572438 ↗
  • Toobert DJ, Glasgow RE, Strycker LA, Barrera M Jr, Radcliffe JL, Wander RC, Bagdade JD. Biologic and quality-of-life outcomes from the Mediterranean Lifestyle Program: a randomized clinical trial. Diabetes Care. 2003 Aug;26(8):2288-93. doi: 10.2337/diacare.26.8.2288. PubMed 12882850 ↗
  • Toobert DJ, Strycker LA, Glasgow RE, Barrera M, Bagdade JD. Enhancing support for health behavior change among women at risk for heart disease: the Mediterranean Lifestyle Trial. Health Educ Res. 2002 Oct;17(5):574-85. doi: 10.1093/her/17.5.574. PubMed 12408202 ↗
  • Toobert DJ, Strycker LA, Glasgow RE, Bagdade JD. If you build it, will they come?. Reach and Adoption associated with a comprehensive lifestyle management program for women with type 2 diabetes. Patient Educ Couns. 2002 Oct-Nov;48(2):99-105. doi: 10.1016/s0738-3991(02)00120-9. PubMed 12401412 ↗

Individual participant data

Plan to share: Undecided

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00142701
Lead sponsor
Oregon Research Institute
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Sponsor
First posted
Sep 2, 2005
Start date
Apr 1999
Primary completion
Sep 2004
Completion
Mar 2005
Last update
Feb 8, 2016

Study contacts

Deborah Toobert
Oregon Research Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion